-
Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease
-
Utilization of Phosphorylated Alpha-Synuclein Skin Biopsy Testing in a Movement Disorders Center
-
Utilizing the 15-item modification of the PSPRS rating scale (mPSPRS-15) as the primary endpoint for future clinical trials in progressive supranuclear palsy
-
Utilizing the Global Parkinson’s Genetics Program (GP2) to develop a precision medicine recruitment protocol
-
Utilizing the Levodopa Challenge Test to Clarify Clinical Complaints Following Levodopa Administration: A Case Series
-
Utilizing Virtual Reality in Educational Programs for Parkinson’s Disease Rehabilitation: A Review of Current Literature and Future Directions
-
Vagus nerve ultrasound and its association with non-motor symptoms in parkinson’s disease
-
Valbenazine Improves Chorea Across Multiple Body Regions in Adults With Huntington’s Disease
-
Valbenazine Improves the Burden and Symptoms of Tardive Dyskinesia: Topline Results from the Phase 4 KINECT-PRO Study
-
Validating Real-World Evidence for Identifying Adverse Events Related to a Deep Brain Stimulation Implant
- « Previous Page
- 1
- …
- 174
- 175
- 176
- 177
- 178
- …
- 181
- Next Page »